Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6200
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCraig Wallington-Gatesen
dc.contributor.authorLisa M. Eberten
dc.contributor.authorKate Vandykeen
dc.contributor.authorM. Zahied Johanen
dc.contributor.authorMark DeNichiloen
dc.contributor.authorLih Y. Tanen
dc.contributor.authorKay K. Myo Minen
dc.contributor.authorBenjamin M. Weimannen
dc.contributor.authorBrenton W. Eberten
dc.contributor.authorStuart M. Pitsonen
dc.contributor.authorAndrew C. W. Zannettinoen
dc.contributor.authorClaudine S. Bonderen
dc.date.accessioned2024-08-08T03:26:11Z-
dc.date.available2024-08-08T03:26:11Z-
dc.date.issued2021-
dc.identifier.citationMolecular Oncology, 2021, Volume 16 (6), p.1221-1240en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6200-
dc.language.isoenen
dc.publisherWileyen
dc.titleDesmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myelomaen
dc.typeArticleen
dc.identifier.doi10.1002/1878-0261.13055-
dc.rights.holderCraig Wallington-Gatesen
dc.identifier.journaltitleMolecular Oncology-
dc.identifier.external96818419-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypeArticle-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

114
checked on Dec 21, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.